AXSMAxsome Therapeutics, Inc.

$8B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20,484

Operating Income

-$28M

Net Income

-$27M

EPS (Diluted)

$-1.42

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$38M

Total Liabilities

$17M

Stockholders' Equity

$22M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$20,484	-$3,542	-478.3%
Operating Income	-$28M	-$9M	-199.5%
Net Income	-$27M	-$12M	-122.8%

AXSM FY 2016 Earnings — Axsome Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena